COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03899610
Brief Title: A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D) (KGOG3046)

First Submitted : March 28, 2019
First Submitted that Met QC Criteria : March 31, 2019
First Posted : April 2, 2019

Last Update Submitted that Met QC Criteria : August 15, 2019
Last Update Posted : August 20, 2019